CELU
Celularity IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$39.22M
P/E Ratio
—
EPS
$-3.33
Beta
0.70
52W High
$4.35
52W Low
$1.01
50-Day MA
$1.27
200-Day MA
$1.94
Dividend Yield
—
Profit Margin
-198.80%
Forward P/E
—
PEG Ratio
—
About Celularity Inc
Celularity Inc. is a leading biotechnology firm focused on transforming the landscape of regenerative medicine through its unique therapeutic cellular products derived from the placenta. With a strong pipeline of next-generation immunotherapies, including allogeneic off-the-shelf solutions, the company aims to enhance treatment efficacy while reducing associated complications for cancer and other serious illnesses. Driven by an experienced leadership team and strategic partnerships, Celularity is well-positioned to address significant unmet medical needs, solidifying its role as a key player in the rapidly evolving field of advanced therapeutics.
Fundamentals
| Revenue (TTM) | $40.58M |
| Gross Profit (TTM) | $20.54M |
| EBITDA | $-41.35M |
| Operating Margin | -243.20% |
| Return on Equity | -6367.00% |
| Return on Assets | -25.00% |
| Revenue/Share (TTM) | $1.69 |
| Book Value | $-0.71 |
| Price-to-Book | 9.89 |
| Price-to-Sales (TTM) | 0.97 |
| EV/Revenue | 2.604 |
| EV/EBITDA | -36.78 |
| Quarterly Earnings Growth (YoY) | -61.30% |
| Quarterly Revenue Growth (YoY) | -43.20% |
| Shares Outstanding | $28.84M |
| Float | $18.42M |
| % Insiders | 36.53% |
| % Institutions | 12.97% |
Historical Volatility
HV 10-Day
51.37%
HV 20-Day
55.61%
HV 30-Day
63.91%
HV 60-Day
66.25%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/10/2026